Does Rallies track congressional trades in ANGO?

Yes. Rallies tracks politician and congressional stock disclosures for ANGO, including reported purchases, sales, dates, owners, and trade amounts when available.

Is ANGO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ANGO. It does not provide personalized investment advice.

ANGO (AngioDynamics, Inc.) Stock Analysis - Politician Trades

AngioDynamics, Inc. (ANGO) is a publicly traded Healthcare sector company. As of May 21, 2026, ANGO trades at $11.81 with a market cap of $457.40M and a P/E ratio of -15.46. ANGO moved +3.15% today. Year to date, ANGO is -10.73%; over the trailing twelve months it is +24.19%. Its 52-week range spans $5.83 to $13.99. Analyst consensus is strong buy with an average price target of $16.00. Rallies surfaces ANGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ANGO stock?

Recent politician trading activity in ANGO includes disclosures from Debbie Wasserman Schultz, Debbie Wasserman Schultz, and Debbie Wasserman Schultz. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

ANGO Key Metrics

Key financial metrics for ANGO
Metric	Value
Price	$11.81
Market Cap	$457.40M
P/E Ratio	-15.46
EPS	$-0.76
Dividend Yield	0.00%
52-Week High	$13.99
52-Week Low	$5.83
Volume	0
Avg Volume	0
Revenue (TTM)	$313.73M
Net Income	$-31.39M
Gross Margin	54.30%

Congressional Trades in ANGO

Debbie Wasserman Schultz sale ANGO on Oct 20, 2025 (amount: $15.00K).
Debbie Wasserman Schultz sale ANGO on Jul 16, 2025 (amount: $15.00K).
Debbie Wasserman Schultz purchase ANGO on Jun 27, 2025 (amount: $15.00K).

Latest ANGO News

AngioDynamics Down 5.8% with RSI at 9.16 as EPS Estimates Rise 24.1% — Apr 11, 2026
AngioDynamics Raises Sales Guidance Again, EPS Loss Range $0.30 to $0.23 — Apr 2, 2026
AngioDynamics Q3 Revenue Rises 8.9% to $78.4M, EPS Misses Estimates — Apr 2, 2026
Veeva Systems Q4 EPS Rises 18.4% to $2.06; Revenues Hit $836M — Mar 5, 2026
AngioDynamics Expands NanoKnife EU Indications and Schedules Leerink Presentation — Feb 23, 2026

Recent ANGO Insider Trades

Weiss Lawrence T bought 10.00K (~$118.10K) on Oct 21, 2025.
Trowbridge Stephen A bought 890 (~$9.93K) on Oct 13, 2025.
Clemmer James C bought 10.00K (~$111.50K) on Oct 9, 2025.

ANGO Analyst Consensus

3 analysts cover ANGO: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.00.

Common questions about ANGO

Which politicians traded ANGO stock?: Recent politician trading activity in ANGO includes disclosures from Debbie Wasserman Schultz, Debbie Wasserman Schultz, and Debbie Wasserman Schultz. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in ANGO?: Yes. Rallies tracks politician and congressional stock disclosures for ANGO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ANGO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ANGO. It does not provide personalized investment advice.